Published in J Clin Invest on November 01, 2006
Epac increases melanoma cell migration by a heparan sulfate-related mechanism. Am J Physiol Cell Physiol (2009) 1.54
The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci U S A (2008) 1.49
Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice. Arterioscler Thromb Vasc Biol (2015) 1.40
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol Ther (2013) 1.28
The paradoxical patent ductus arteriosus. J Clin Invest (2006) 1.18
Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol (2008) 1.06
T-type Ca2+ channels promote oxygenation-induced closure of the rat ductus arteriosus not only by vasoconstriction but also by neointima formation. J Biol Chem (2009) 0.98
Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev (2012) 0.97
Transcriptional regulation during development of the ductus arteriosus. Circ Res (2008) 0.96
Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice. Circulation (2010) 0.94
Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. Br J Pharmacol (2008) 0.94
Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A. J Biol Chem (2008) 0.93
Inhibition of EP4 signaling attenuates aortic aneurysm formation. PLoS One (2012) 0.93
Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closure. Pediatr Res (2009) 0.89
Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonates. PLoS One (2011) 0.88
A protein kinase A and Wnt-dependent network regulating an intermediate stage in epithelial tubulogenesis during kidney development. Dev Biol (2012) 0.88
Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway. Br J Pharmacol (2009) 0.81
BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus. Proc Natl Acad Sci U S A (2015) 0.80
Transcription profiles of endothelial cells in the rat ductus arteriosus during a perinatal period. PLoS One (2013) 0.80
Sarcalumenin is essential for maintaining cardiac function during endurance exercise training. Am J Physiol Heart Circ Physiol (2009) 0.79
Involvement of Na+/Ca2+ exchanger in migration and contraction of rat cultured tendon fibroblasts. J Physiol (2009) 0.78
Spontaneous prenatal ductal closure: postnatal diagnosis? Pediatr Cardiol (2008) 0.78
Current Perspectives on Pathobiology of the Ductus Arteriosus. J Clin Exp Cardiolog (2012) 0.77
Thromboxane A(2) receptor stimulation promotes closure of the rat ductus arteriosus through enhancing neointima formation. PLoS One (2014) 0.76
Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus. Circ Res (2010) 0.76
Arterial graft with elastic layer structure grown from cells. Sci Rep (2017) 0.75
Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization. PLoS One (2017) 0.75
Prostaglandin dehydrogenase is a target for successful induction of cervical ripening. Proc Natl Acad Sci U S A (2017) 0.75
Prostanoid receptors: structures, properties, and functions. Physiol Rev (1999) 8.60
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34
Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med (1976) 3.30
Molecular mechanisms in intimal hyperplasia. J Pathol (2000) 2.83
Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med (1976) 2.59
Persistent ductus arteriosus: most probably a primary congenital malformation. Br Heart J (1977) 2.59
Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 2.59
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature (1997) 2.56
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest (2001) 2.55
Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem (2001) 2.45
Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med (2002) 2.26
Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun (1998) 2.04
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest (2000) 1.74
The pharmacology of the ductus arteriosus. Pharmacol Rev (1998) 1.66
Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med (1999) 1.64
Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med (1993) 1.64
Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem (2005) 1.60
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem (2001) 1.58
Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem (2003) 1.44
Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr (1978) 1.31
The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr (1980) 1.29
Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest (1991) 1.28
Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys (2001) 1.20
Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. Mol Cell Biol (2005) 1.08
Multiple transcripts of Ca2+ channel alpha1-subunits and a novel spliced variant of the alpha1C-subunit in rat ductus arteriosus. Am J Physiol Heart Circ Physiol (2005) 1.07
Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol (1997) 1.07
Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol (1985) 1.04
Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus. J Pharmacol Exp Ther (1994) 1.02
Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on g protein-coupled receptor expression, signaling, and vasomotor control. Circulation (2004) 1.02
Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci U S A (1995) 1.01
Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics (1998) 0.98
Cell-extracellular matrix interactions in the ductus arteriosus and perinatal pulmonary circulation. Semin Perinatol (1996) 0.97
Adenylyl cyclase 3 mediates prostaglandin E(2)-induced growth inhibition in arterial smooth muscle cells. J Biol Chem (2001) 0.97
Formation of intimal cushions in the ductus arteriosus as a model for vascular intimal thickening. An immunohistochemical study of changes in extracellular matrix components. Atherosclerosis (1992) 0.96
Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res (2005) 0.95
Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 0.95
Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res (2004) 0.91
Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. Br J Pharmacol (2002) 0.90
Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol (2003) 0.83
Human ductus arteriosus. A histological study on the relation between ductal maturation and gestational age. Acta Pathol Jpn (1985) 0.79
Management of patent ductus arteriosus in preterm babies. Ann Thorac Surg (1980) 0.77
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med (2004) 6.16
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83
Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature (2002) 3.60
Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol (2005) 3.51
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest (2002) 3.21
Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell (2007) 2.96
Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med (2009) 2.68
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med (2002) 2.37
Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol (2005) 2.24
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost (2005) 2.07
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res (2002) 2.02
Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients. Ther Apher Dial (2012) 2.01
Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain (2005) 1.94
Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem (2005) 1.81
Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem (2002) 1.81
Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. Biochem Biophys Res Commun (2004) 1.69
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69
The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney Int (2012) 1.66
Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem (2003) 1.66
Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol (2005) 1.65
Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A (2003) 1.64
EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis (2002) 1.64
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res (2004) 1.61
Birth regulates the initiation of sensory map formation through serotonin signaling. Dev Cell (2013) 1.61
Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem (2003) 1.61
Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem (2005) 1.60
Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors. J Physiol (2003) 1.59
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation (2008) 1.56
Epac increases melanoma cell migration by a heparan sulfate-related mechanism. Am J Physiol Cell Physiol (2009) 1.54
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension (2013) 1.52
Henoch-Schonlein purpura presenting duodenal involvement similar to superior mesenteric artery syndrome in a girl. Eur J Pediatr (2006) 1.51
Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats. J Hypertens (2011) 1.51
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A (2002) 1.51
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertens Res (2012) 1.50
Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med (2006) 1.49
DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus. J Physiol Sci (2011) 1.49
Asparagine repeat function in a Plasmodium falciparum protein assessed via a regulatable fluorescent affinity tag. Proc Natl Acad Sci U S A (2011) 1.46
Caveolin gene transfer improves glucose metabolism in diabetic mice. Am J Physiol Cell Physiol (2009) 1.45
Histamine synthesis is required for granule maturation in murine mast cells. Eur J Immunol (2013) 1.44
Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem (2003) 1.44
Urinary beta 2-microglobulin in premature infants with chorioamnionitis and chronic lung disease. J Pediatr (2003) 1.44
Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology. Pediatr Nephrol (2006) 1.43
Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J Biol Chem (2006) 1.41
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation (2006) 1.40
Lipopolysaccharide Delays Closure of the Rat Ductus Arteriosus by Induction of Inducible Nitric Oxide Synthase But Not Prostaglandin E2. Circ J (2016) 1.39
Superior mesenteric artery syndrome: risk factor for duodenal involvement in Henoch-Schönlein purpura. Pediatr Int (2011) 1.39
Circumstances and outcomes of out-of-hospital cardiac arrest in elementary and middle school students in the era of public-access defibrillation. Circ J (2014) 1.38
Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation (2007) 1.37
Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis (2003) 1.36
Motor dysfunction in type 5 adenylyl cyclase-null mice. J Biol Chem (2003) 1.32
Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration. J Biol Chem (2004) 1.31
Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clin Cancer Res (2009) 1.31
Method for single-cell microarray analysis and application to gene-expression profiling of GABAergic neuron progenitors. Neurosci Res (2008) 1.29
Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol (2007) 1.28
Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res (2009) 1.26
Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res (2003) 1.25
Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol (2007) 1.23
Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn (2006) 1.22
Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series. J Rheumatol (2012) 1.20
COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. Am J Pathol (2010) 1.20
Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development (2009) 1.18
Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 1.18
Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol (2009) 1.16
Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem (2002) 1.16
Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol (2007) 1.15
Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan. Circ Arrhythm Electrophysiol (2009) 1.14
Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J Leukoc Biol (2008) 1.13
Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem (2008) 1.13
Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res (2013) 1.12
Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci (2009) 1.11
Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat (2002) 1.11
Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol (2004) 1.10
Hyaluronan in limb morphogenesis. Dev Biol (2007) 1.09
The prostanoid EP4 receptor and its signaling pathway. Pharmacol Rev (2013) 1.08
Norovirus-associated encephalopathy. Pediatr Infect Dis J (2006) 1.08
Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. Mol Cell Biol (2005) 1.08
Multiple transcripts of Ca2+ channel alpha1-subunits and a novel spliced variant of the alpha1C-subunit in rat ductus arteriosus. Am J Physiol Heart Circ Physiol (2005) 1.07
Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci U S A (2004) 1.07